Abstract:Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in women. Despite the significant burden of CVD, knowledge and awareness of its risk factors among women are low. This review aimed to identify CVD awareness, knowledge, and risk factors for women of reproductive age from different countries and variables that influence health outcomes. Studies published from 2000 to 2023 were reviewed using PubMed, ScienceDirect, Elsevier, and electronic databases. A total of 50 studies were found, and 41 were excluded. The keywords used were "Knowledge of the risk factor of heart disease," "cardiac risk factors," "cardiovascular disease," "heart disease awareness," and "heart disease," combined with "women" and "reproductive age." The review revealed significant gaps in the general awareness and knowledge of CVD risk factors among women of reproductive age. Many women were unaware of the symptoms and risk factors associated with CVD, leading to delayed diagnosis and poorer outcomes. Lack of education, low socioeconomic status, and limited access to healthcare were identified as contributing factors to this knowledge gap. Young women, particularly those with poor pregnancy outcomes, demonstrated limited awareness and perception of CVD risk. The findings suggest significant gaps in general awareness, knowledge of CVD risk, risk factors among women of reproductive age from different countries, and factors that influence their health outcomes. Targeted interventions are urgently needed to improve awareness and knowledge of CVD among women of reproductive age. Efforts should focus on educating women about CVD risk factors and prevention strategies before symptoms arise. Addressing socioeconomic and educational disparities is crucial to bridging the gap in awareness. By enhancing awareness and knowledge, women can be empowered to take preventive actions and reduce their risk of developing CVD. As a result, we recommend that there are significant opportunities to educate women about CVD risk and prevention before symptoms arise. In addition, there is a need to develop effective interventions to raise awareness among women of reproductive age to close the gap in awareness and knowledge of CVD.

Closing the gap: cardiovascular disease in women

The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

Advancing womens cardiovascular health: an international lens on the Joint British Cardiovascular Societies consensus statement

Ethical Considerations in the Conduct of Clinical Pharmacokinetic Studies

Cardiovascular Disease and the Female Disadvantage

Primary prevention of cardiovascular disease in women

Closing the sex gap in cardiovascular mortality by achieving both horizontal and vertical equity

Advancing the access to cardiovascular diagnosis and treatment among women with cardiovascular disease: a joint British Cardiovascular Societies’ consensus document

Do Women Suffer from Them Differently?

Update on sex specific risk factors in cardiovascular disease

Pelvic osteotomy: an alternative to total hip replacement in the young adult.

An adaptive mutation in adenylate kinase that increases organismal fitness is linked to stability-activity trade-offs.

The role of mediators in the response to thermal injury

Global Inequalities in Access to Cardiovascular Health Care: Our Greatest Challenge.

Engaging women in decision-making about their heart health: a literature review with patients' perspective

Cardiovascular disease in women: take it to heart

Awareness and Knowledge of Cardiovascular Diseases and Its Risk Factors Among Women of Reproductive Age: A Scoping Review

Cardio-rheumatology: the cardiovascular, pharmacological, and surgical risks associated with rheumatological diseases in women

Gender Disparities on Access to Care and Coronary Disease Management

Abstract 11028: Gender Inequality in Enrollment in Late-Breaking Cardiovascular Clinical Trials

Unique cardiometabolic factors in women that contribute to modified cardiovascular disease risk